can glp 1 damage kidneys GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity Role of GLP-1 Agonists &

Description

Obesity and metabolic disorders are on the rise globally

The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trial Phytother Res

Chronic diseases such as obesity and diabetes, cardiovascular and inflammatory bowel diseases (IBD) share common features in their pathology

GLP-1 Receptor Agonists and Aspiration Risk: From Universal Holding to Risk-Based Perioperative Management Review Abstract Purpose The rapid adoption ofglucagon-like peptide-1 receptor agonists (GLP-1 RAs)anddual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonistshas transformed the management of type 2 diabetes mellitus and obesity

This review examines the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on different heart failure phenotypes with preserved ejection fraction